| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2025 | Feb 27, 2025 | Arcus Biosciences, Inc. | Director | Buy | 82.5 | +20,000 | 2.18% | ✗ | $201.2K |
| Apr 23, 2021 | Apr 26, 2021 | Arcus Biosciences, Inc. | Director | Buy | 65.0 | +4,133 | 0.46% | ✗ | $129.7K |
| Oct 19, 2018 | Oct 19, 2018 | SI-BONE, Inc. | 10% Owner | Buy | 95.0 | +325,000 | 7.94% | ✗ | $4.9M |
| May 12, 2015 | May 13, 2015 | COLLEGIUM PHARMACEUTICAL, INC | 10% Owner | Buy | 95.0 | +150,000 | 5.36% | ✗ | $1.8M |
| Oct 27, 2014 | Oct 29, 2014 | Protara Therapeutics, Inc. | 10% Owner | Buy | 95.0 | +143,962 | 9.67% | ✗ | $1.4M |
| May 29, 2012 | May 31, 2012 | TALPHERA, INC. | 10% Owner | Buy | 92.5 | +284,698 | 7.34% | ✗ | $968K |
| Feb 16, 2011 | Feb 18, 2011 | TALPHERA, INC. | 10% Owner | Buy | 100.0 | +1,235,943 | 46.79% | ✗ | $6.2M |